New French study: Vaccines provide good protection against severe COVID-19

The corona vaccines provide good protection against serious illness, a new large study from France confirms.

The research was carried out by Epi-Phare, an independent research group that works closely with the French authorities.

Information on 22 million people over the age of 50 was included in the study. The results showed that vaccinated people had a 90% lower probability of being hospitalized and dying of COVID-19. The vaccines apparently worked almost as well against the delta variant as previous virus variants.

The vaccines provided 92% protection against the delta variant for people between the ages of 50 and 75, and 84% protection for those who were older. However, the protection against the delta variant has only been studied over a period of one month. Epi-Phare wants to extend the study with figures for two more months.

The corona vaccines of Pfizer/BioNTech, Moderna, and AstraZeneca have been included in the study. The results confirm previous findings from Israel, the United States, and the United Kingdom. The study in France indicates that vaccines provide good protection against serious illness even five months after vaccination.

Do you have a news tip for Norway Today? We want to hear it. Get in touch at info@norwaytoday.no